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The number of chronic obstructive pulmonary disease (COPD) patients is increasing
and the readmission rate is remarkably high amongst these patients. Healthcare
professionals and managers have financial and workforce-related pressures due to
increasing demand with severe financial cuts, as well as staff shortages. Many studies
have previously been conducted using Markov modelling and Monte-Carlo simulation
for COPD, however, a discrete event simulation (DES) model or an operational model
at this scale has never been developed. Therefore, a DES model incorporating health
economics and readmission dynamics is developed to improve the management of
patients and efficiencies.
We, firstly, conceptualised the pathway for COPD patients in collaboration with the
COPD team of a hospital and community service in London. Then, the impact of post
exacerbation pulmonary rehabilitation (PEPR) policy is tested for a demonstration of
the developed simulation tool. We notice that the PEPR is cost-effective with
improvements in QALY, reduction in emergency readmissions, occupied bed days and
its associated costs. The tool can be used for assessing the impact of a wide range of
scenarios on key performance metrics (such as activity, service hours, readmission
rate, financial implications etc) by key decision makers.
Abstract
Amongst many scenarios and interventions (such as more referral to COPD services,
vaccination, optimising medicine etc.), the scenario related to post exacerbation
pulmonary rehabilitation (PEPR) policy is chosen for demonstration. PEPR suggests
referring patients pulmonary rehabilitation within a short time after discharge (7-15
days) from hospital following an acute exacerbation of COPD. PEPR has the highest
potential of improving patient outcomes and reduction in the risk of hospital
readmission and length of stay6-8. The effect of PEPR varies in the studies, so four sets of
scenarios (worst, pessimistic, realistic and optimistic) are established for the indicators of
interest (such as reduction in readmission, decrease in LoS etc).
The model was run 50 times for a simulation period of 3.5 years (with a warm-up period
of 0.5 year) to measure key performance indicators. The results exclusively show that;
1. The use of PEPR decreases inpatient admissions, occupied bed days, the penalty due
to the 30-day readmission, service hours of nurses (see Table 1).
2. Besides, the number of patients completing the PR programme is increased due to
more referrals to PR.
3. In brief, the realistic and optimistic scenarios proved that the PEPR is cost-effective
with cost reduction and gained QALY (see Figure 2).
4. Lastly, the incremental cost-effectiveness ratio (ICER) of PEPR for each scenario is
found to be acceptable.
Introduction
The COPD patient pathway is constituted and verified with the COPD team (specialist
consultants, nurses, physiotherapists, and service manager) from the Royal Free
London. The pathway (see Figure 1) shows the possible movement of patients,
referral/discharge points and departments that are usually visited by COPD patients
within a hospital setting as well as the course of the disease.
DES is chosen as the simulation tool because it is more capable and convenient to
model the hospital environment where processes and events happen at discrete
times. Input parameters;
1. COPD patient records are acquired from the Hospital Episodes Statistics (HES),
2. Pathway related parameters from the COPD team,
3. The literature was consulted for data, e.g. disease severity transition, cost of
treatments and bed days etc.
Methods and Materials
Our model is the first of its kind that assesses the quantifiable impact of re-designing
COPD services using DES as well as integrates COPD readmissions and health economics.
According to our findings, the use of PEPR leads to positive outcomes in terms of
reduction in the number of readmissions, total COPD treatment costs, staff workload and
levels of activity. Even the ICER value of worst and pessimistic scenarios are way lower
than NICE’s threshold for ICER. Nevertheless, increased use of PR requires financial
investment and agile action, in the form of staffs, room and planning activities.
The positive impact of the use of PEPR can be generalised to other providers in the UK.
Variety of scenarios can be tested by healthcare professionals by adjusting input
parameters using the simulation tool. Community services (CS) play a vital role in the
management of COPD so the next stage of the study is to incorporate CS and test other
scenarios around outpatient and CS.
Discussion
Baseline Worst Pessimistic Realistic Optimistic
Number of Inpatient Admission 1090 1090 1081 1040 998
Number of 30-day Readmission 169 169 158 143 122
Total Cut on Reimbursement 
(Penalty)
£124,341 £121,563 £113,035 £103,358 £87,810
Total Cost of Inpatient Bed days £1,730,106 £1,696,231 £1,674,286 £1,620,007 £1,559,771
Total nurse service hours (TSNH) 39185 38842 38374 37185 35870
Total PR Cost to CCG £204,016 £319,580 £322,668 £326,229 £330,037
Chronic Obstructive Pulmonary Disease (COPD) is chronic obstruction of lung airflow
and the common terms 'chronic bronchitis' and 'emphysema' are included within the
COPD diagnosis1. It is a progressive but preventable lung disease and the world’s third
deadliest disease2. Smoking is the main cause of COPD and people over the age of 35
and heavy smokers are risk group for the disease. About 3.2 million people in the UK
are estimated to be living with COPD, but sadly, 2.2 million are undiagnosed3.
COPD is one of the most costly chronic conditions4 and around 1 million in-patient bed
days are used by COPD patients5. The readmission is very high amongst COPD patients
and the 30-day readmission policy penalties for the emergency admissions after 30
days of discharge following an admission.
While there are many modelling studies about cost-effectiveness of new drugs,
therapies and treatments for COPD, there are no known models that capture
individual patient pathway within COPD services. Therefore, this study aims to develop
a discrete event simulation (DES) tool for the COPD pathway so as to enhance the
efficiency and quality of patient care by assessing the impact of changes or new
policies. The core objectives of this project are;
1. constructing a COPD patient pathway,
2. engaging health economics and readmission dynamics to the simulation tool,
3. designing a user-friendly interface to enable hospital managers and practitioners to
use the model.
Results
Figure 1 Conceptualised pathway for CODP patients
Figure 2 Simulation results of total cost and total QALY for each scenario
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